Kotak analyst Alankar Garude upgraded Mankind Pharma Ltd (MANKIND:IN) from Add (2) to Buy (1) with a price target of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE